Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Antibody entities : Pfizer, inc. save search
Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate
Published: 2022-12-01 (Crawled : 07:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: 0.36%
H: 1.68%
C: 1.53%
valneva candidate disease report antibody children vaccine
ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: 5.27%
H: 0.0%
C: -2.17%
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.59%
H: 1.21%
C: 0.71%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: 0.57%
H: 1.16%
C: 0.94%
offering treatment antibody hiv potential positive
Kintor Pharma Announces First Patient Dosing in Multi-Regional Global Phase II Clinical Trial of ALK-1 Antibody and Nivolumab Combination Therapy for the Treatment of Advanced Hepatocellular Carcinoma
Published: 2022-05-04 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.81%
H: 2.0%
C: 1.57%
treatment pharma antibody trial therapy nivolumab
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates
Published: 2021-03-18 (Crawled : 17:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.73%
H: 1.24%
C: 0.68%
antibody drug commercialization license
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
Published: 2021-01-20 (Crawled : 13:01) - globenewswire.com
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: 0.16%
H: 0.05%
C: -0.79%
BNTX | News | $88.09 -0.45% -0.35% 230K
|
Health Technology
|
| O: -0.28%
H: 1.04%
C: -1.13%
covid results vaccine antibody sars-cov-2
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
Published: 2021-01-08 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: 0.27%
H: 0.98%
C: -0.08%
BNTX | News | $88.09 -0.45% -0.35% 230K
|
Health Technology
|
| O: 4.71%
H: 3.16%
C: 2.33%
covid vaccine antibody sars-cov-2 in vitro
BioInvent receives $3 million payment related to selection of antibodies under collaboration with Pfizer Inc.
Published: 2020-12-23 (Crawled : 05:10) - prnewswire.com
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: 0.73%
H: 1.73%
C: 1.16%
collaboration antibody
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.